AU7389300A - Methods of administration of glycopyrrolate compositions - Google Patents

Methods of administration of glycopyrrolate compositions

Info

Publication number
AU7389300A
AU7389300A AU73893/00A AU7389300A AU7389300A AU 7389300 A AU7389300 A AU 7389300A AU 73893/00 A AU73893/00 A AU 73893/00A AU 7389300 A AU7389300 A AU 7389300A AU 7389300 A AU7389300 A AU 7389300A
Authority
AU
Australia
Prior art keywords
administration
methods
glycopyrrolate compositions
glycopyrrolate
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73893/00A
Inventor
Balaji Venkataraman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi Pharma Inc
Original Assignee
First Horizon Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Horizon Pharmaceutical Corp filed Critical First Horizon Pharmaceutical Corp
Publication of AU7389300A publication Critical patent/AU7389300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
AU73893/00A 1999-08-02 2000-08-01 Methods of administration of glycopyrrolate compositions Abandoned AU7389300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14682399P 1999-08-02 1999-08-02
US60146823 1999-08-02
PCT/US2000/040526 WO2001008681A1 (en) 1999-08-02 2000-08-01 Methods of administration of glycopyrrolate compositions

Publications (1)

Publication Number Publication Date
AU7389300A true AU7389300A (en) 2001-02-19

Family

ID=22519140

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73893/00A Abandoned AU7389300A (en) 1999-08-02 2000-08-01 Methods of administration of glycopyrrolate compositions

Country Status (2)

Country Link
AU (1) AU7389300A (en)
WO (1) WO2001008681A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
DE10136404A1 (en) * 2001-07-26 2003-02-20 Johannes Wohlrab Topical medicament for treating or preventing hyperhidrosis, e.g. hyperhidrosis axillaris, comprises glycopyrrolate compound in gel and/or colloid-containing vehicle system
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
MXPA05004278A (en) 2002-10-25 2005-10-05 Foamix Ltd Cosmetic and pharmaceutical foam.
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US7091236B1 (en) 2003-08-20 2006-08-15 Sciele Pharma, Inc. Method for increasing the bioavailability of glycopyrrolate
WO2006069998A2 (en) 2004-12-27 2006-07-06 Beiersdorf Ag Glycopyrrolate in cosmetic preparations
DE102005029390A1 (en) * 2005-06-23 2007-01-04 Beiersdorf Ag Combination, useful as cosmetic deodorant and antitranspirants, comprises glycopyrronium bromide and active materials e.g. boundary surface-active substances, polyols and hydrocolloids
DE102005029386A1 (en) * 2005-06-23 2007-01-11 Beiersdorf Ag Combination, useful as cosmetic deodorant and antitranspirants, comprises glycopyrronium bromide and active materials e.g. boundary surface-active substances, polyols and hydrocolloids
AU2006206252B2 (en) * 2005-01-19 2009-11-05 Neurohealing Pharmaceuticals, Inc. Methods and compositions for decreasing saliva production
PT1986642E (en) 2006-02-13 2014-01-30 Orient Pharma Samoa Co Ltd Combination of alpha-2 receptor agonist (clonidine) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
GB0602857D0 (en) * 2006-02-13 2006-03-22 Daniolabs Ltd The treatment of sialorrhoea
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
AU2008268465A1 (en) * 2007-06-22 2008-12-31 Sciele Pharma, Inc. Transdermal delivery system comprising glycopyrrolate to treat sialorrhea
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
GB0715790D0 (en) * 2007-08-13 2007-09-26 Summit Corp Plc Drug combination for the treatment of sialorrhoea
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20100055045A1 (en) 2008-02-26 2010-03-04 William Gerhart Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (en) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Topical tetracycline compositions.
JP6114841B2 (en) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． Glycopyrrolate salt
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
CA2998353A1 (en) * 2015-09-11 2017-03-16 Bodor Laboratories, Inc. Methods and compositions for soft anticholinergic zwitterions
AU2016318595B2 (en) 2015-09-11 2021-07-08 Bodor Laboratories, Inc. Methods and compositions for soft anticholinergic esters
WO2017139794A2 (en) * 2016-02-12 2017-08-17 United States Government As Represented By The Department Of Veterans Affairs Bowel care using iontophoresis
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11110054B2 (en) 2018-05-09 2021-09-07 Slayback Pharma Llc Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885282A (en) * 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling

Also Published As

Publication number Publication date
WO2001008681A1 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AUPQ419099A0 (en) Novel compositions and methods
AU3867400A (en) Methods of using bioelastomers
AU7719100A (en) Compositions of tocol-soluble therapeutics
AU2115301A (en) Dental compositions
AU3192700A (en) Medicinal compositions
AU2557500A (en) Methods of making compounds
AU4318000A (en) Agarobiose-containing composition
AU5326100A (en) Pharmaceutical compositions and methods for use
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU1887401A (en) Medicinal composition
AU1290501A (en) Composition
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU6460400A (en) Pharmaceutical compositions
AU2681500A (en) Rapidly-soluble compositions
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU1718301A (en) Use of sugar compositions
AUPQ197899A0 (en) Biomedical compositions
AU5085300A (en) Compositions
AU6460200A (en) Pharmaceutical compositions
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU6720100A (en) Depigmenting compositions
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase